Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus Type 1 (HIV-1)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Infection, Human Immunodeficiency Virus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Ditan Hospital Capital Medical University, Beijing, China, Beijing, China
Contact: Study coordinator (Zhang F Jie, M.D., Ph.D.) · treatment@chinaaids.cn · 010-84322581
Contact: Study coordinator (Cai W Ping, M.D., Ph.D.) · gz8hcwp@126.com · 020-83822586

Study leads

Zhang F Jie, M.D., Ph.D.
Principal Investigator
Beijing Ditan Hospital
Cai W Ping, M.D., Ph.D.
Principal Investigator
Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults

Human Immunodeficiency Virus

Abroad (travel likely)RecruitingPHASE1

Kampala, Uganda

Low Dose Naltrexone for Pain in Patients With HIV

Human Immunodeficiency Virus · Chronic Neuropathic Pain

Abroad (travel likely)RecruitingPHASE4

Atlanta, United States · Atlanta, United States

A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV

HPV · Human Papilloma Virus · Human Immunodeficiency Virus

Abroad (travel likely)RecruitingPHASE4

Surrey, Canada · Vancouver, Canada